Life Sciences

FDA warns Kimberly-Clark

Device Regulation Alert: Safety, Compliance and Reimbursement News, September 22, 2008

Kimberly-Clark significantly changed 12 models of previously approved sterilization wraps and needed marketing clearance before selling the devices, according to an FDA warning letter.

Kimberly-Clark initially told the FDA it did not make significant changes to the wraps and marketed them under the previous approval. However, the FDA disagreed and said the devices are adulterated and misbranded because the company did not adequately justify why it did not submit 510(k)s or PMAs for the devices.

Comments

0 comments on “FDA warns Kimberly-Clark

 

    ePharm5 InDepth
  • ePharm5 InDepth

    EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...

  • Complete Guide to Lab Safety, 3rd Ed.

    The third edition of this popular resource makes training and compliance easier by consolidating regulations from all...

Most Popular